Clinical, Paraclinical, and Evolutionary Profiles of Kidney Failure in Gold Miners Hospitalized in a Nephrological Service in a Sub-Saharan African Country
Table 4
Average value of various biochemical and haematological analyses performed at admission in 50 gold miner patients with kidney failure.
Biological analysis
n (%)
Average ± SD
Range
Plasma urea (mmol/L)
50 (100)
40.9 ± 14.8
10.3–83.0
Creatininemia (μmol/L)
50 (100)
2338.0 ± 791.4
594–4651
Uricemia (μmol/L)
28 (56)
705.7 ± 211.5
435–1281
Natremia (mmol/L)
50 (100)
131.5 ± 9.1
109–146
Kaliemia (mmol/L)
50 (100)
5.0 ± 1.4
2.6–7.5
Bicarbonatemia (mmol/L)
36 (72)
18.4 ± 5.4
7–29
Calcemia (mmol/L)
50 (100)
1.7 ± 0.4
0.9–2.3
Phosphataemia (mmol/L)
48 (96)
3.0 ± 0.9
0.7–5.3
Protidemia (g/L)
39 (78)
64.9 ± 9.1
51–89
Proteinuria (g/24 hours)
50 (100)
2.0 ± 0.9
0.5–4.7
Hemoglobinemia (g/dL)
50 (100)
8.6 ± 2.3
4.2–14.5
Rate of leukocytes (el/mm3)
50 (100)
10672.2 ± 3456
4600–18523
Rate of platelets (el/mm3)
50 (100)
162283 ± 3824
88000–410000
SD: standard deviation; el: elements; n: number of patients for whom test results were available.
